Positive PureVu data gives Motus GI a brief bump

This study gives us solid insight into how the Pure-Vu system can support patients that need a colonoscopy for urgent reasons in an inpatient environment as well as patients with medical issues that have significant issues with tolerating current preparation regimes.” MOTS shares jumped some 17% yesterday in pre-market trading on the news, before opening up 10.6% at $5.13 apiece. But as the broader market declined yesterday – the Dow Jones Industrial average closed down -1.2% at 25,304.19, while the S&P 500 index also ended down -1.2% at 2,751.59 and the NASDAQ index lost -0.7%, closing at 7,371.77 – so did Motus GI shares, which closed down -3.0% at $4.50 apiece. The stock was trading at $4.48 per share today in mid-day activity, down -0.4%. The post Positive PureVu data gives Motus GI a brief bump appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Wall Street Beat MOTUS GI Source Type: news